1995
DOI: 10.1006/bbrc.1995.1076
|View full text |Cite
|
Sign up to set email alerts
|

Curcumin, an Anti-tumor Promoter and Anti-inflammatory Agent, Inhibits Induction of Nitric Oxide Synthase in Activated Macrophages

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

14
232
2
2

Year Published

1997
1997
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 422 publications
(250 citation statements)
references
References 0 publications
14
232
2
2
Order By: Relevance
“…[15,33] and possible suppression of BACE1 induction, it is likely that no one mechanism is involved. Curcumin also inhibits known amyloid response pathways including JNK kinase and iNOS expression in vitro [5,12,23] and in vivo [10,13] and in CNS (our data). Thus, curcumin should be able to suppress not only A␤ but key aspects of the response to A␤ that are JNK-and iNOS-dependent including LTP inhibition [30], reported to depend on JNK, iNOS, and microglial radicals [31].…”
Section: Curcumin Is a Combined Polyphenolic Anti-oxidant/nsaid That supporting
confidence: 66%
“…[15,33] and possible suppression of BACE1 induction, it is likely that no one mechanism is involved. Curcumin also inhibits known amyloid response pathways including JNK kinase and iNOS expression in vitro [5,12,23] and in vivo [10,13] and in CNS (our data). Thus, curcumin should be able to suppress not only A␤ but key aspects of the response to A␤ that are JNK-and iNOS-dependent including LTP inhibition [30], reported to depend on JNK, iNOS, and microglial radicals [31].…”
Section: Curcumin Is a Combined Polyphenolic Anti-oxidant/nsaid That supporting
confidence: 66%
“…PPAR-␥ agonists are presumed to exist in the media with 10% FBS (29,36,56). Activation of PPAR-␥ is required for curcumin to inhibit HSC activation, including reduced cell growth and suppressed ECM gene expression (8,9). In the present report, we observed that blockade of PPAR-␥ activation by its antagonist abrogated the inhibitory effect of curcumin on CTGF gene expression (Fig.…”
Section: Discussionsupporting
confidence: 53%
“…Curcumin inhibits lipid peroxidation (45,49), nitric oxide synthase activity (9), and production of ROS (31). These unique features might allow curcumin to succeed where other regular antioxidants have failed in the inhibition of hepatic fibrogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…Throughout the Orient, it has traditionally been used to good therapeutic effect, particularly as an anti-inflammatory [12], and many of its therapeutic effects have been confirmed by modern scientific research. Such effects include antioxidant [27], anti-inflammatory [24,28,29], anticarcinogenic and antimicrobial [30][31][32], hepatoprotective [32], thrombosuppressive [33], cardiovascular (i.e., as protection against myocardial infarction) [29,34,35], hypoglycemic [36][37][38], and antiarthritic (i.e., as protection against rheumatoid arthritis) [39], The most compelling and key rationale for the continuing traditional therapeutic use of curcumin is its extremely good safety profile. To date, no studies in either animals [40,41] or humans [42] have discovered any toxicity associated with the use of curcumin, and it is clear that curcumin is not toxic even at very high doses.…”
Section: Q4mentioning
confidence: 99%